Ophthalmic Photocoagulator Market Size to Worth Around USD 313.2 Mn by 2030
The global Ophthalmic Photocoagulator market size was reached at USD 180.6 billion in 2020 and is projected to surpass US$ 313.2 million by 2030, expanding growth at a CAGR of 10.7% from 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38415
Growth Factors
The global influence of COVID-19 on eye health and the rise in the incidence of increasing ocular diseases, such as and age-related macular edema, are the key factors fuelling the market growth.
The growing elderly population and the increasing prevalence of diabetes-related blindness are also projected to fuel the market growth. Various eye diseases are quite frequent in the geriatric population. The National Institute on Aging (NIA) estimated that the elderly population would reach 72 million people by 2030. Diabetic retinopathy has become more common as the diabetic epidemic has spread throughout the world. Individuals’ average time spent on a digital screen has risen, resulting in a variety of eye-related pain and disorders.
Report Highlights
The diabetic retinopathy segment held the largest share of 38.2% in 2020 and is expected to grow at the fastest rate over the forecast period. The prevalence rate as per the American Academy of Ophthalmology, 2019 for retinopathy for all adults with diabetes aged 40 worldwide has been estimated at 34.6% (93 million people).
The green scan laser photocoagulator segment dominated the market and held a share of 43.4% in 2020. The green laser wavelength (532 nm) is considered to be a standard laser as it offers versatile applications and excellent absorption.
The multicolor scan laser photocoagulator segment is expected to grow at the fastest rate of 10.3% during the forecast period. The multicolor scan laser allows the selection of multiple wavelengths in one versatile machine, making it easier for the surgeons. 577 nm yellow, 532 nm green, and 647 nm red are the most often used wavelengths and combinations of any two or all three wavelengths at the same time
Hospitals held the largest share of 46.4% in 2020 due to the extensive use of ophthalmic lasers in hospital settings. Furthermore, the growing number of hospitals in emerging countries, the improvement of existing eye care infrastructure at government medical colleges and district hospitals, and the construction of new eye care infrastructure are expected to aid the segment growth.
North America dominated the market by capturing a share of 444.0% in 2020. Chronic eye illnesses such as age-related macular edema, diabetic retinopathy, and glaucoma are becoming more common as a result of high stress and unhealthy lifestyles, which are high-impact key drivers for the North American market. According to the International Diabetes Federation (IDF), the U.S. has the highest diabetes rate among 38 developed countries, with approximately 30 million people suffering from the disease.
Asia Pacific is expected to grow at the fastest rate of 10.9% during the forecast period. The increasing incidence of optical diseases, which includes glaucoma, age-related macular degeneration, and diabetic retinopathy, is creating a demand for photocoagulation in this region.
| Report Coverage | Details |
| Market Size | US$ 313.2 million by 2030 |
| Growth Rate | CAGR of 10.7% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Application, Wavelength, End use |
| Regional Scope | North America, Latin America, Europe, Asia Pacific, MEA |
| Companies Mentioned | Lumenis; IRIDEX Corporation; Alcon Inc.; Quantel Medical; NIDEK CO., LTD.; Johnson & Johnson Vision Care, Inc.; TOPCON CORPORATION; Bausch & Lomb Incorporated; Meridian Medical Group |
Key Players
- Lumenis
- IRIDEX Corporation
- Alcon Inc.
- Quantel Medical
- NIDEK CO., LTD.
- Johnson & Johnson Vision Care, Inc.
- TOPCON CORPORATION
- Bausch & Lomb Incorporated
- Meridian Medical Group
Market Segmentation
- Application Outlook
- Glaucoma
- Diabetic Retinopathy
- Age-related Macular Degeneration
- Macular Edema
- Others
- Wavelength Outlook
- Green Scan Laser Photocoagulator
- Yellow Scan Laser Photocoagulator
- Red Scan Laser Photocoagulator
- Multicolor Scan Laser Photocoagulator
- End-use Outlook
- Hospitals
- Ambulatory Surgery Centers
- Ophthalmology Clinics
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38415
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Ophthalmic Photocoagulator Market, By Application
7.1. Ophthalmic Photocoagulator Market, by Application, 2021-2030
7.1.1. Glaucoma
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Diabetic Retinopathy
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Age-related Macular Degeneration
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Macular Edema
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Ophthalmic Photocoagulator Market, By Wavelength
8.1. Ophthalmic Photocoagulator Market, by Wavelength, 2021-2030
8.1.1. Green Scan Laser Photocoagulator
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Yellow Scan Laser Photocoagulator
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Red Scan Laser Photocoagulator
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Multicolor Scan Laser Photocoagulator
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Ophthalmic Photocoagulator Market, By End User
9.1. Ophthalmic Photocoagulator Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Ambulatory Surgery Centers
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Ophthalmology Clinics
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Ophthalmic Photocoagulator Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Application (2016-2030)
10.1.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.1.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Application (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Application (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Application (2016-2030)
10.2.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.2.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Application (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Application (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Application (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Application (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Application (2016-2030)
10.3.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.3.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Application (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Application (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Application (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Application (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Application (2016-2030)
10.4.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Application (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Application (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Application (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Application (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Application (2016-2030)
10.5.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Application (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Application (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Wavelength (2016-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2030)
Chapter 11. Company Profiles
11.1. Lumenis
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. IRIDEX Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Alcon Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Quantel Medical
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. NIDEK CO., LTD.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Johnson & Johnson Vision Care, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. TOPCON CORPORATION
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Bausch & Lomb Incorporated
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Meridian Medical Group
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38415
Contact Us:
Vision Research Reports
Call: +1 9197 992 333